HUSSMAN STRATEGIC ADVISORS, INC. PRAX PRAXIS PRECISION MEDICINES I

Ownership history in HUSSMAN STRATEGIC ADVISORS, INC.  ·  8 quarters on record

AI Ownership Summary

HUSSMAN STRATEGIC ADVISORS, INC. reported PRAXIS PRECISION MEDICINES I (PRAX) in 8 quarterly 13F filings from 2024 Q2 through 2026 Q1. Peak portfolio weight reached 0.6% in 2025 Q4. The latest visible filing shows PRAX at 0.29% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this PRAX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was HUSSMAN STRATEGIC ADVISORS, INC.'s position in PRAXIS PRECISION MEDICINES I, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

PRAX was reported at 0.29% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.6% in 2025 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q2 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How HUSSMAN STRATEGIC ADVISORS, INC. held PRAX — position size vs. price
% of Fund (quarterly)    PRAX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 8 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED 50.0% +8.8% 4,200 -4,200 -50.0% 0.29% $1.4M 2026-05-11 $331.81
2025 Q4 REDUCED 20.0% +9.3% 8,400 -2,100 -20.0% 0.60% $2.5M 2026-02-02 $309.11
2025 Q3 UNCHANGED 10,500 0% 0.12% $556K 2025-11-03 $181.99
2025 Q2 UNCHANGED 10,500 0% 0.10% $442K 2025-08-05 $47.79
2025 Q1 UNCHANGED 10,500 0% 0.10% $398K 2025-05-05 $38.96
2024 Q4 REDUCED 50.0% -50.8% 10,500 -10,500 -50.0% 0.24% $808K 2025-02-03 $80.26
2024 Q3 UNCHANGED 21,000 0% 0.30% $1.2M 2024-11-01 $68.33
2024 Q2 INITIATED 21,000 0.24% $869K 2024-08-01 $56.95

FAQ About HUSSMAN STRATEGIC ADVISORS, INC. and PRAX

These are the practical questions this page is built to answer before you even open the full history table.

How long has HUSSMAN STRATEGIC ADVISORS, INC. reported owning PRAX?

HUSSMAN STRATEGIC ADVISORS, INC. reported PRAX across 8 quarterly 13F filings, from 2024 Q2 through 2026 Q1.

What was the largest reported PRAX position in HUSSMAN STRATEGIC ADVISORS, INC.'s portfolio?

The largest reported portfolio weight for PRAX was 0.60% in 2025 Q4.

What is the latest reported PRAX position on this page?

The most recent filing on this page is 2026 Q1, when HUSSMAN STRATEGIC ADVISORS, INC. reported 4,200 shares, equal to 0.29% of portfolio, with an estimated market value of $1.4M.

What does the chart on this PRAX ownership page compare?

The chart compares HUSSMAN STRATEGIC ADVISORS, INC.'s quarterly PRAX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did HUSSMAN STRATEGIC ADVISORS, INC. time their PRAX position?

Based on 13F filing dates vs. subsequent PRAX price moves, HUSSMAN STRATEGIC ADVISORS, INC. correctly timed 2 out of 3 reported position changes (67%). The annualised alpha on PRAX relative to SPY over the holding period was +124.3%.

← Back to HUSSMAN STRATEGIC ADVISORS, INC. Holdings